Proteomic Changes in Methicillin-Resistant Staphylococcus aureus Exposed to Cannabinoids

Research output: Contribution to journalJournal articleResearchpeer-review

3 Citations (Scopus)
2 Downloads (Pure)

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is a major human pathogen that causes a wide range of infections. Its resistance to β-lactam antibiotics complicates treatment due to the limited number of antibiotics with activity against MRSA. To investigate development of alternative therapeutics, the mechanisms that mediate antibiotic resistance in MRSA need to be fully understood. In this study, MRSA cells were subjected to antibiotic stress from methicillin in combination with three cannabinoid compounds and analyzed using proteomics to assess the changes in physiology. Subjecting MRSA to nonlethal levels of methicillin resulted in an increased production of penicillin-binding protein 2 (PBP2). Exposure to cannabinoids showed antibiotic activity against MRSA, and differential proteomics revealed reduced levels of proteins involved in the energy production as well as PBP2 when used in combination with methicillin.

Original languageEnglish
JournalJournal of Natural Products
Volume86
Issue number7
Pages (from-to)1690-1697
Number of pages8
ISSN0163-3864
DOIs
Publication statusPublished - 28 Jul 2023

Fingerprint

Dive into the research topics of 'Proteomic Changes in Methicillin-Resistant Staphylococcus aureus Exposed to Cannabinoids'. Together they form a unique fingerprint.

Cite this